Maximus Inc (MMS):企業の財務・戦略的SWOT分析

◆英語タイトル:Maximus Inc (MMS) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1183
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Business and Consumer Services
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Maximus Inc (MMS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Maximus Inc (Maximus) is a provider of business process solutions that enable governments to serve people with a range of health and human services programs. The company offers a variety of business process management and technology solutions for improving productivity, precision, accountability and efficiency of government-sponsored programs. Its portfolio includes consulting services, administration services, and software development, operations and management. The company also provides child support services, tax credit, and workforce services. Maximus serves federal, state and local human service and government health agencies. It collaborates with government agencies in the US, the UK, Australia, New Zealand, Canada, and Saudi Arabia. Maximus is headquartered in Reston, Virginia, the US.

Maximus Inc Key Recent Developments

Aug 21,2019: MAXIMUS to discuss leveraging data analytics at the National Home & Community Based Services Conference
Aug 19,2019: MAXIMUS to present at the National Association for Medicaid Program Integrity Conference on implementing effective community engagement
Jun 24,2019: MAXIMUS contact centers in Georgia, Indiana, New York and Texas recognized as center of excellence by benchmarkportal

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Maximus Inc – Key Facts
Maximus Inc – Key Employees
Maximus Inc – Key Employee Biographies
Maximus Inc – Major Products and Services
Maximus Inc – History
Maximus Inc – Company Statement
Maximus Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Maximus Inc – Business Description
Business Segment: Outside the US
Overview
Performance
Key Stats
Business Segment: US Federal Services
Overview
Performance
Key Stats
Business Segment: US Health and Human Services
Overview
Performance
Key Stats
Geographical Segment: Australia
Performance
Geographical Segment: Rest of World
Performance
Geographical Segment: The UK
Performance
Geographical Segment: The US
Performance
Maximus Inc – Corporate Strategy
Maximus Inc – SWOT Analysis
SWOT Analysis – Overview
Maximus Inc – Strengths
Maximus Inc – Weaknesses
Maximus Inc – Opportunities
Maximus Inc – Threats
Maximus Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Recent Developments
Aug 21, 2019: MAXIMUS to discuss leveraging data analytics at the National Home & Community Based Services Conference
Aug 19, 2019: MAXIMUS to present at the National Association for Medicaid Program Integrity Conference on implementing effective community engagement
Jun 24, 2019: MAXIMUS contact centers in Georgia, Indiana, New York and Texas recognized as center of excellence by benchmarkportal
Section 5 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Maximus Inc, Key Facts
Maximus Inc, Key Employees
Maximus Inc, Key Employee Biographies
Maximus Inc, Major Products and Services
Maximus Inc, History
Maximus Inc, Other Locations
Maximus Inc, Subsidiaries
Maximus Inc, Key Competitors
Maximus Inc, Ratios based on current share price
Maximus Inc, Annual Ratios
Maximus Inc, Annual Ratios (Cont...1)
Maximus Inc, Annual Ratios (Cont...2)
Maximus Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Maximus Inc, Performance Chart (2015 - 2019)
Maximus Inc, Ratio Charts

★海外企業調査レポート[Maximus Inc (MMS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Colby Pharmaceutical Co-製薬・医療分野:企業M&A・提携分析
    Summary Colby Pharmaceutical Company (Colby Pharma) is a biopharma company that focuses on the development of safe and effective small molecule analgesic, anti-inflammatory drug, and immunobiologic products. Its product portfolio includes Oral small molecule analgesics CPC-123 & CPC-111 for post-sur …
  • Hydrogenics Corp (HYG):企業の財務・戦略的SWOT分析
    Hydrogenics Corp (HYG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Zenkyoren:企業の戦略・SWOT・財務情報
    Zenkyoren - Strategy, SWOT and Corporate Finance Report Summary Zenkyoren - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Under Armour, Inc.:企業の戦略・SWOT・財務情報
    Under Armour, Inc. - Strategy, SWOT and Corporate Finance Report Summary Under Armour, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Canon Medical Systems Corp:企業の戦略的SWOT分析
    Canon Medical Systems Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • CAT Telecom Public Co Ltd:企業の戦略的SWOT分析
    CAT Telecom Public Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Karachaganak Petroleum Operating BV:企業の戦略的SWOT分析
    Karachaganak Petroleum Operating BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Escher Group Holdings plc:企業の戦略・SWOT・財務情報
    Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report Summary Escher Group Holdings plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Environmental Container Systems Inc:企業の戦略・SWOT・財務情報
    Environmental Container Systems Inc - Strategy, SWOT and Corporate Finance Report Summary Environmental Container Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • PT Aerowisata:企業の戦略・SWOT・財務分析
    PT Aerowisata - Strategy, SWOT and Corporate Finance Report Summary PT Aerowisata - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ralph Lauren Corporation:戦略・SWOT・企業財務分析
    Ralph Lauren Corporation - Strategy, SWOT and Corporate Finance Report Summary Ralph Lauren Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Pelago Bioscience AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Pelago Bioscience AB (Pelago Bioscience) is a developer of patented cellular thermal shift assay for use in determination and quantification of drug–target interactions. The company utilizes patented CETSA technology which enables direct, in situ physiologically relevant measurements of targ …
  • SANUWAVE Health Inc (SNWV):医療機器:M&Aディール及び事業提携情報
    Summary Sanuwave Health Inc (Sanuwave), formerly Rub Music Enterprises Inc, is a medical device company that develops and commercializes noninvasive biological response activating devices. The company offers products such as dermapace, which is used in the treatment of chronic and acute conditions o …
  • TBG Diagnostics Ltd (TDL)-医療機器分野:企業M&A・提携分析
    Summary TBG Diagnostics Ltd (TBG Diagnostics), formerly Progen Pharmaceuticals Ltd, is molecular diagnostics company that researches, develops, manufactures and markets molecular diagnostics kits, instruments and services. Its products are used in a wide range of applications such as medical researc …
  • Wellcome Trust Sanger Institute:医療機器:M&Aディール及び事業提携情報
    Summary Wellcome Trust Sanger Institute (Sanger Institute) a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research a …
  • Olympus Corporation:企業のM&A・事業提携・投資動向
    Olympus Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Olympus Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Sirtex Medical Ltd (SRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Sirtex Medical Ltd (Sirtex Medical) is a medical device company that develops and markets device for the treatment of liver cancer. The company’s sir-spheres microsphere is a medical device, which is used in selective internal radiation therapy for liver tumors. Its product Y-90 resin micros …
  • Verona Pharma Plc (VRP)-製薬・医療分野:企業M&A・提携分析
    Summary Verona Pharma Plc (Verona Pharma) is a clinical-stage biotechnology company, which focuses on the research, discovery and development of first-in-class therapeutic drugs for the treatment of chronic respiratory and inflammatory diseases. The company's lead candidate, RPL554 is a bronchodilat …
  • PepsiCo Inc:企業のM&A・事業提携・投資動向
    PepsiCo Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PepsiCo Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Cancer Research Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Cancer Research Institute (CRI) is a non-profit cancer research organization that discovers and develops immunotherapy for treating various types of cancer. The organization offers clinical trials for breast cancer, colorectal cancer, lung cancer, melanoma and prostate cancer. Its programs c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆